Eli Lilly and Co

(LLY)

Health Care · Pharmaceutical Preparations · US

1,112.00

-10.50 (-0.94%)

FINNHUB · 2h ago
Valuation Chart
Financial Statements
EDGAR · 1d ago
Line (USD)FY2025FY2024FY2023FY2022
Revenue65.18B45.04B34.12B28.54B
Pretax Income25.73B12.68B6.55B6.81B
Income Tax5.09B2.09B1.31B561.60M
Net Income20.64B10.59B5.24B6.24B
EPS (diluted)22.9511.715.806.90
Diluted Shares899.30M904.06M903.28M904.62M
Interest Expense485.90M331.60M
About

Employees: —
Key Ratios (TTM)
P/E48.91x
EV/EBITDA
EV/Sales15.37x
P/B38.04x
P/FCF
Operating margin
Net margin31.7 %
ROE77.8 %
Debt / Equity
Dividend yield
Revenue growth (YoY)44.7 %
EPS growth (YoY)96.0 %
Beta
EDGAR · 1d ago
News
An unhandled error has occurred. Reload 🗙

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.